Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMMY: Empagliflozin after acute myocardial infarction
2016-004591-22Phase 3Completed
- Sponsor
- Medical University of Graz
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in myocardial infarction (MI), heart failure (HF), sponsored by Medical University of Graz. Started Feb 2017; status: completed.
02
Drugs
empagliflozin
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on 2016-004591-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004591-22.